UTHR

UNITED THERAPEUTICS CORP

UTHR·91307C102·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

UTHR (UNITED THERAPEUTICS CORP) is held by 284 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($2.9B), Avoro Capital Advisors LLC ($1.5B), VANGUARD PORTFOLIO MANAGEMENT LLC ($1B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 137 funds bought UTHR.

284
Holders
(23 Elite)
$18.6B
Total Value
48% (286)
Consensus
137 buying - 149 selling
13F: Insider & Congress: Updated regularly
UTHR

Smart Money Verdict

View all
Loading verdict
Held by 284 funds
23 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 28, 2026 · Activists Aug 14, 2026 · Congress Nov 21, 2025

InsiderRAROTHBLATT MARTINE ASell $361KAug 27, 2026
InsiderRAROTHBLATT MARTINE ASell $253KAug 27, 2026
InsiderRAROTHBLATT MARTINE ASell $522KAug 27, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
5.3M(-1.9%)$2.9B0.0%+42.31%
0
Increased
2.8M(+5.6%)$1.5B13.5%+108.58%
67
Decreased
1.9M(-4.2%)$1B0.0%+3.62%
0
Decreased
1.9M(-2.0%)$1B0.0%+3.62%
0
Increased
1.9M(+2.9%)$1B0.0%+110.68%
33
Decreased
1.7M(-4.4%)$925.8M1.3%+383.17%
0
Decreased
1.4M(-39.1%)$747.2M0.1%+45.13%
0
Decreased
996,598(-19.2%)$538.9M0.0%+131.71%
0
Increased
624,068(+1.3%)$338.1M0.6%+98.05%
44
Decreased
546,002(-33.9%)$294.6M0.1%+69.21%
0
Increased
527,904(+3.0%)$286M0.1%+108.60%
32
Decreased
473,409(-10.4%)$256.5M0.0%+19.84%
0
Decreased
473,109(-22.2%)$256.3M0.0%+94.92%
0
Increased
467,209(+9.1%)$253.1M0.2%+3.22%
40
Increased
436,699(+6.7%)$236.6M0.0%+47.51%
33
Decreased
430,844(-1.3%)$233.4M0.0%+131.87%
0
Increased
409,074(+166.7%)$221.6M0.1%+1.80%
49
Increased
340,275(+22.4%)$184.4M0.0%+8.81%
37
Decreased
322,995(-1.3%)$175M0.2%+201.48%
0
Decreased
304,692(-15.5%)$165.1M0.0%+21.24%
0

Showing 1-20 of 296

1 / 15
UTHRUTHRUNITED THERAPEUTICS CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used